COVID-19: C-CAMP’s CIDA announces its week 4 picks with solutions to address pandemic

Centre for Cellular And Molecular Platforms (C-CAMP)'s COVID-19 Innovations Deployment Accelerator C-CIDA in its Week 4 has selected 6 companies with solutions that are making headway in addressing the pandemic

0
135

Bengaluru: Centre for Cellular And Molecular Platforms (C-CAMP)’s COVID-19 Innovations Deployment Accelerator C-CIDA in its fourth week has selected six companies with solutions that are making headway in addressing the pandemic.

These are ‘Eyestem’ for a novel screening platform for anti-COVID-19 drugs, ‘Kerasiev’ – a  technology to control viral contaminants in wastewater, Innaumation for therapeutics approaches, ‘Pluss Technologies’ for cold chain support for viral swabs, ‘R. R. Animal Healthcare’ for surface sanitization and ‘DNAXperts’ for an indigenously developed rapid diagnostics kit.

While a few of these companies are ready to deploy immediately, some will be in the game longer with platform technologies in areas that hold immense potential for impact in India and globally.

Dr Taslimarif Saiyed, CEO & Director, C-CAMP, the founding organization of C-CIDA has said “In fact, C-CIDA Week 4 line up of Stars reflects the diversity of solutions being put forth by Indian startup community. These are not mainstream but bold, holistic approaches. Even if not investor-friendly, technologies such as these are a huge bet for us as a society right now. The scale is not just India but the world.”

C-CAMP along with its other C-CIDA partners, Action COVID-19 Team or ACT and Social Alpha are set to handpick a select few of these innovations for grant funding and investment opportunities easing their path to eventual adoption by the public healthcare system.

C-CIDA a dedicated COVID-19 Innovations Accelerator aims at identifying, fast-tracking and providing handholding support to innovations that are near-ready for deployment. The platform is a  multi-partner coalition of several Indian and global industry and investor bodies including United Nations Health Innovation Exchange (UNHIE), Social Alpha, ACT, PATH, AIC-CCMB, CCMB-CSIR, 91Springboard, India Health Fund, India 2022 Xynteo and MedTechConnect.

C-CAMP launched C-CIDA in late March and since then it has attracted nation-wide response with more than 1000 submitted innovations from all over India and interestingly, some from overseas. The call has earlier selected 25 top innovations in its first three weeks. With this batch of 6 the number climbs to 31! Many more are expected to be announced in the coming weeks.

As C-CIDA enters its second month, the Accelerator has diversified its portfolio from the immediate and urgent necessities to novel and experimental approaches that in the long-run can change the face of the outbreak in India and the world. A few of these products are already in the market. C-CIDA will now facilitate quick deployment by Government and private sectors so that the pandemic can be contained and more lives can be saved.